Related Experiment Video
Updated: Jun 21, 2026

The Antihypertensive Effects and Mechanisms of Huotan Jiedu Tongluo Decoction in Rats with H-Type Hypertension
Published on: May 17, 2024
Hyperhomocysteinemia as an independent risk factor for cardioembolic stroke in the Turkish population
Nida Tascilar1, Sureyya Ekem, Esra Aciman
1Department of Neurology, Zonguldak Karaelmas University Medical Faculty, Kozlu/Zonguldak, Turkey.
Insights
High homocysteine levels are common in Turkish patients with atherosclerotic and cardioembolic stroke. However, hyperhomocysteinemia is an independent risk factor only for cardioembolic stroke.
Area of Science:
- Neurology
- Cardiovascular Medicine
- Biochemistry
Background:
- Homocysteine, an amino acid intermediate, can cause vascular injury and atherosclerotic plaque instability.
- Elevated homocysteine levels are linked to hyperlipidemia and lipoprotein(a), and inversely to HDL cholesterol.
- Previous studies on homocysteine's association with stroke subtypes and risk factors show inconsistent results, potentially due to ethnic variations.
Purpose of the Study:
- To investigate the role of serum homocysteine levels in Turkish patients with atherosclerotic stroke and cardioembolic stroke.
- To determine if hyperhomocysteinemia is an independent risk factor for these stroke subtypes in the Turkish population.
Main Methods:
- Serum homocysteine, lipoprotein(a), and traditional stroke risk factors (hypertension, diabetes, smoking) were measured.
- 103 patients with large-vessel atherosclerotic stroke, 37 with cardioembolic stroke, and 37 controls were analyzed.
- Statistical analysis included logistic regression and correlation tests.
Main Results:
- Hypertension was a significant risk factor across all patient groups (p = 0.001).
- Hyperhomocysteinemia (≥15.90 µmol/L) was more prevalent in both atherosclerotic (p=0.0435) and cardioembolic stroke patients (p=0.007).
- Hyperhomocysteinemia emerged as an independent risk factor solely for cardioembolic stroke (p=0.023, OR: 5.745) and correlated positively with lipoprotein(a) in atherosclerotic stroke (r=0.227, p=0.035).
Conclusions:
- Hyperhomocysteinemia is frequently observed in Turkish patients with both large-vessel atherosclerotic and cardioembolic stroke.
- Elevated homocysteine is an independent risk factor specifically for cardioembolic stroke within this population.
- The findings highlight the importance of considering homocysteine levels in stroke risk assessment, particularly for cardioembolic events.
Abstract:
Homocysteine, a sulfur-containing amino acid, is an intermediate during the conversion of methionine to cysteine. Homocysteine can cause vascular injury and atherosclerotic plaque instability. In addition, homocysteine may be directly correlated with hyperlipidemia and lipoprotein(a) and inversely with high-density lipoprotein cholesterol. However, the results regarding the association of homocysteine level with subtypes of stroke and traditional risk factors for stroke have been inconsistent, perhaps due to ethnic differences. The aim of this study was to evaluate the role of serum homocysteine levels in Turkish patients diagnosed with atherosclerotic stroke and those with cardioembolic stroke. We measured homocysteine levels, traditional risk factors for stroke (hypertension, diabetes mellitus, and smoking) and lipoprotein(a) levels in 103 patients with large-vessel atherosclerotic stroke, 37 patients with cardioembolic stroke, and 37 controls with normal cranial magnetic resonance imaging. Only hypertension was found to be a risk factor in all patient groups (p = 0.001). Hyperhomocysteinemia (homocysteine level > or = 15.90 micromol/L) was more common in patients with large-vessel atherosclerotic stroke and cardioembolic stroke (p = 0.0435 and p = 0.007, respectively); nevertheless, it was found to be a risk factor only in patients with cardioembolic stroke (p = 0.023; odds ratio (OR): 5.745). Furthermore, in the patients with large-vessel atherosclerotic stroke, hyperhomocysteinemia was positively correlated with the lipoprotein(a) level (r = 0.227, p = 0.035). In conclusion, hyperhomocysteinemia is common in patients with large-vessel atherosclerotic stroke and cardioembolic stroke. More importantly, hyperhomocysteinemia is an independent risk factor only for cardioembolic stroke in the Turkish population.
Related Concept Videos
Blood Studies for Cardiovascular System II: CRP, Hcy, and Cardiac Natriuretic Peptide Markers
These markers indicate stress or strain on the heart muscle:
Natriuretic Peptides (BNP)
Cardiac myocytes produce these hormones in response to ventricular stretching...
Ischemic Stroke l: Introduction
Hemorrhagic Stroke l: Introduction
Hemorrhagic Stroke ll: Pathophysiology
Ischemic Heart Disease: Overview
Atherosclerosis, the primary malefactor, orchestrates this dangerous condition. It manifests as the accumulation of fatty deposits, akin to insidious plaques, within arterial walls. As time elapses, these plaques metamorphose, hardening and narrowing...
Coronary Artery Disease I: Introduction